AGGRASTAT
NDC 25208-901, TIROFIBAN, injection, solution, from Medicure International Inc.
- Product NDC
- 25208-901
- Status
- Listed
- Labeler
- Medicure International Inc
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA020912
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/25208-901 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TIROFIBAN HYDROCHLORIDE3.75 mg/15mL
Pharmacologic classes
Decreased Platelet Aggregation [PE]; Platelet Aggregation Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 25208-901-04 | 25208090104 | 1 VIAL, GLASS in 1 CARTON (25208-901-04) / 15 mL in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/e850111f-e713-41a2-9c65-21c517cf5511Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=25208-901
Use it
Look up 25208-901 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/25208-901 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 25208-901. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.